These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7948299)

  • 1. Thrombolysis in thromboembolic diseases.
    Gulba DC; Dechend R
    Ann Hematol; 1994 Oct; 69(4):S41-57. PubMed ID: 7948299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current developments in thrombolytic therapy using novel plasminogen activators.
    Seifried E; Tanswell P
    Arzneimittelforschung; 1989 Nov; 39(11):1474-82. PubMed ID: 2695093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; del Zoppo G; Yamaguchi T
    Cochrane Database Syst Rev; 2000; (2):CD000213. PubMed ID: 10796329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term outcome of acute massive pulmonary thromboembolism following thrombolysis].
    Liu P; Meneveau N; Schiele F; Bassand JP
    Zhonghua Nei Ke Za Zhi; 2002 Nov; 41(11):750-3. PubMed ID: 12485521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular basis of thrombolysis and its clinical application in stroke.
    Murray V; Norrving B; Sandercock PA; Terént A; Wardlaw JM; Wester P
    J Intern Med; 2010 Feb; 267(2):191-208. PubMed ID: 20175866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Monagle P; Chan A; Massicotte P; Chalmers E; Michelson AD
    Chest; 2004 Sep; 126(3 Suppl):645S-687S. PubMed ID: 15383489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Undesirable side effects in thrombolytic therapy].
    Claus G; Gulba DC
    Z Gesamte Inn Med; 1993; 48(6-7):296-303. PubMed ID: 8333226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Bates SM; Greer IA; Hirsh J; Ginsberg JS
    Chest; 2004 Sep; 126(3 Suppl):627S-644S. PubMed ID: 15383488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical update on thrombolytic use in pulmonary embolism: A focus on intermediate-risk patients.
    Eberle H; Lyn R; Knight T; Hodge E; Daley M
    Am J Health Syst Pharm; 2018 Sep; 75(17):1275-1285. PubMed ID: 29895520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular pharmacology (XIII). The efficacy of different thrombolytic drugs in the treatment of acute myocardial infarct].
    López-Sendón J; López de Sá E; Bobadilla JF; Rubio R; Bermejo J; Delcán JL
    Rev Esp Cardiol; 1995 Jun; 48(6):407-39. PubMed ID: 9324694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of changes in blood fibrinolytic and coagulation parameters during thrombolytic therapy.
    Marder VJ
    Am J Med; 1987 Aug; 83(2A):15-9. PubMed ID: 3115098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2004 Sep; 126(3 Suppl):483S-512S. PubMed ID: 15383482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspect of thrombolytic therapy: a review.
    Ali MR; Salim Hossain M; Islam MA; Saiful Islam Arman M; Sarwar Raju G; Dasgupta P; Noshin TF
    ScientificWorldJournal; 2014; 2014():586510. PubMed ID: 25574487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Menon V; Harrington RA; Hochman JS; Cannon CP; Goodman SD; Wilcox RG; Schünemann HJ; Ohman EM
    Chest; 2004 Sep; 126(3 Suppl):549S-575S. PubMed ID: 15383484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of prehospital thrombolytic therapy in ST-segment elevation acute coronary syndrome (<12 hours).
    Goldstein P; Wiel E
    Minerva Anestesiol; 2005 Jun; 71(6):297-302. PubMed ID: 15886591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.